Table 3.

Comparison of EORTC QLQ-C30 and EORTC QLQ CX 24 scores between uterine cervical cancer patients with low PA and normal PA.

Scores for the QLQ Scales	Phase Angle < 4.45° n = 29 Median (P25-P75)	Phase Angle ≥ 4.45° n = 36 Median (P25-P75)	p-Value
EORTC QLQ-C30 (SCORE 0–100)
Global Health Status/Quality of Life	83.33 (75.00–100.00)	75.00 (58.33–100.00)	0.289
Physical Functioning	80.00 (66.67–93.33)	93.33 (73.33–100.00)	0.102
Role Functioning	100.00 (33.33–100.00)	100.00 (100.00–100.00)	0.057 *
Emotional Functioning	83.33 (58.33–100.00)	66.67 (41.67–91.67)	0.231
Cognitive Functioning	100.00 (66.67–100.00)	100.00 (66.67–100.00)	0.716
Social Functioning	100.00 (66.67–100.00)	100.00 (83.33–100.00)	0.548
Fatigue	33.33 (0.0–66.67)	22.22 (0.0–33.33)	0.203
Nausea and Vomiting	0.0 (0.0–16.67)	0.0 (0.0–0.0)	0.263
Pain	16.67 (0.0–50.00)	0.0 (0.0–33.33)	0.358
Dyspnea	0.0 (0–33.33)	0.0 (0.0–33.33)	0.980
Insomnia	0.0 (0.0–66.67)	0.0 (0.0–66.67)	0.959
Loss of Appetite	33.33 (0.0–100.00)	0.0 (0.0–0.0)	0.005 *
Constipation	0.0 (0–33.33)	0.0 (0.0–0.0)	0.275
Diarrhea	0.0 (0.0–66.67)	0.0 (0.0–0.0)	0.145
Financial Difficulties	66.67 (0.0–66.67)	33.33 (0.0–100.00)	0.725
EORTC QLQ CX 24 (SCORE 0–100)
Body Image	100.00 (77.80–100.00)	100.00 (66.70–100.00)	0.830
Sexual Activity	0.0 (0.0–0.0)	0.0 (0.0–33.33)	0.200
Sexual Enjoyment	27.70 (27.70–27.70)	27.70 (27.70–27.70)	0.191
Sexual/Vaginal Functioning	62.20 (62.20–62.20)	62.20 (62.20–62.20)	0.404
Symptom Experience	12.10 (6.10–18.20)	9.10 (3.0–24.20)	0.444
Lymphoedema	0.0 (0.0–33.33)	0.0 (0.0–33.33)	0.645
Peripheral Neuropathy	0.0 (0.0–33.33)	0.0 (0.0–33.33)	0.647
Menopausal Symptoms	0.0 (0.0–33.33)	0.0 (0.0–100.0)	0.039 *
Sexual Concern	0.0 (0.0–66.70)	0.0 (0.0–100.0)	0.572

* Significant p-value < 0.05. Mann–Whitney U test. Nonparametric distribution values. Median (interquartile interval).